Sanofi
SELECTIVE GLUCAGON RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING PURPOSES
Last updated:
Abstract:
The present invention relates to exendin-4 peptide analogues which selectively bind and activate the glucagon receptor and comprise a chelating moiety capable of binding a metal ion and their use, for example in PET imaging.
Status:
Application
Type:
Utility
Filling date:
12 Dec 2016
Issue date:
20 Aug 2020